Pharmion acquires Innohep
Executive Summary
Pharmion will sell the low molecular weight heparin product Innohep (tinzaparin) after acquiring U.S. rights from Danish firm LEO Pharma. DuPont returned Innohep rights after the company's acquisition by Bristol-Myers Squibb...